Skip to ContentSkip to Navigation
Practical matters How to find us dr. C.T. (Kristel) Muijs


Clinical 3D/4D cumulative proton dose assessment methods for thoracic tumours with large motion

Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe

Diaphragm-Based Position Verification to Improve Daily Target Dose Coverage in Proton and Photon Radiation Therapy Treatment of Distal Esophageal Cancer

External validation of a prediction model for two-year mortality in esophageal cancer cohorts

First clinical experiences in treating oesophageal cancer with intensity-modulated proton therapy

Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study

Locoregional Residual Esophageal Cancer after Neo-adjuvant Chemoradiotherapy and Surgery Regarding Anatomic Site and Radiation Target Fields A Histopathologic Evaluation Study: A Histopathologic Evaluation Study

Robustness assessment of clinical adaptive proton and photon radiotherapy for oesophageal cancer in the model-based approach

Role of mTOR through Autophagy in Esophageal Cancer Stemness

Trade-off in lung and heart dose and the impact on target robustness in VMAT of oesophageal cancer

Read more